Minimum Investment
About Company
Company Name: Himalaya Nutravedics India Limited
Industry / Sector: Ayurvedic & Nutraceutical Formulations
Founded Year: June 2022
Promoters: Rohit Asawa, Divya Asawa, Chanda Asawa, Rama Raju Penmatsa
Himalaya Nutravedics India Limited is engaged in the manufacturing, marketing and distribution of Ayurvedic and nutraceutical formulations in India and also undertakes third-party contract manufacturing for other Ayurvedic and nutraceutical companies. The Company manufactures a diversified portfolio comprising classical (Shastric) Ayurvedic formulations, proprietary Ayurvedic formulations and nutraceutical supplements. Its products are available in multiple dosage forms, including soft gelatin capsules, hard gelatin capsules, tablets, liquid orals and medicated oils. The products cater to therapeutic and wellness areas such as gut health, cardiac and metabolic wellness, diabetes management, pain management, immunity, women's wellness and general wellness. Himalaya Nutravedics operates through a hybrid business model comprising its own branded products and third-party contract manufacturing. The Company operates an integrated manufacturing facility in Hyderabad, Telangana, which is compliant with WHO-GMP standards and holds registrations and licences from AYUSH and FSSAI, along with certifications including ISO 9001:2015, ISO 22000:2018, HACCP, HALAL and KOSHER. As of July 31, 2026, the Company had 86 full-time employees.
IPO Basic Details
| Company Name | Himalaya Nutravedics India Limited |
| IPO Type | SME IPO |
| Price Band | ₹100 – ₹106 |
| Lot Size | 1200 Shares |
| Total Issue Size | 24,99,600 Equity Shares (₹26.50 Cr) |
IPO Strengths & Risks
Strengths
- Geographic expansion across India
- Long-standing supplier and customer relationships
- Integrated multi-dosage manufacturing capabilities
- Doctor acceptance supported by product performance
- Broad therapeutic coverage across Ayurvedic and nutraceutical segments
Risks
- Labour intensive operations may face risks from strikes or wage demands
- Highly competitive Ayurvedic and nutraceutical industry with established players
- Regulatory risks related to sourcing, testing and quality of raw materials
- Dependence on key personnel and practitioners for product adoption
- Working capital intensive business model
IPO Important Dates
| IPO Open Date | 22 Sep 2026 |
| IPO Close Date | 24 Sep 2026 |
| Basis of Allotment | 25 Sep 2026 |
| Refund Initiation | 28 Sep 2026 |
| Demat Credit Date | 28 Sep 2026 |
| Listing Date | 29 Sep 2026 |
| Anchor Investor Date | - |
| UPI Mandate Deadline | - |
IPO Objectives
- Capital expenditure for machinery and equipment – -
- Funding working capital requirements – -
- Debt repayment – -
- General corporate purposes – Balance Amount
Investor Reservation
| QIB Quota | 49.90% of Net Issue (11,84,400 shares) |
| Retail Quota | 35.09% of Net Issue (8,32,800 shares) |
| HNI Quota | - |
| Employee Quota | - |
| Shareholder Quota | - |
| Anchor Investor Allocation | - |
Market Lot Details
| Application | Lot Size | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 2 Lots | 2400 | ₹2,54,400 |
| Retail Maximum | 2 Lots | 2400 | ₹2,54,400 |
| S-HNI Minimum | 3 Lots | 3600 | ₹3,81,600 |
| S-HNI Maximum | 7 Lots | 8400 | ₹8,90,400 |
| B-HNI Minimum | 8 Lots | 9600 | ₹10,17,600 |
Key Performance Indicators (KPI)
| ROE | 63.87% |
| ROCE | 36.41% |
| RoNW | - |
| PAT Margin | 17.16% |
| EBITDA Margin | 18.82% |
| EPS | ₹11.72 (Pre-IPO), ₹8.39 (Post-IPO) |
| NAV per share | - |
| Debt to Equity | 0.31 |
| P/E Ratio | - |
| Industry P/E | - |
Company Financial Data
| Period | Assets | Total Income | PAT | EBITDA | Net Worth | Borrowings |
|---|---|---|---|---|---|---|
| FY2026 | ₹24.42 Cr | ₹43.12 Cr | ₹7.39 Cr | ₹8.10 Cr | ₹16.38 Cr | ₹5.13 Cr |
| FY2025 | ₹10.82 Cr | ₹21.00 Cr | ₹2.23 Cr | ₹2.99 Cr | ₹6.75 Cr | ₹1.76 Cr |
| FY2024 | ₹6.09 Cr | ₹14.43 Cr | ₹0.43 Cr | ₹0.94 Cr | ₹1.34 Cr | ₹3.24 Cr |
Grey Market Premium
| GMP Price | Not Available |
| Kostak Rate | Not Available |
| Subject to Sauda | Not Available |
| Last Updated | Not Available |
| Estimated Listing Price | TBA |
IPO Subscription Data
| Total Subscription | Pending |
| QIB (Ex Anchor) | Pending |
| HNI Subscription | Pending |
| Retail Subscription | Pending |
| Anchor | - |
IPO Intermediaries
Registrar: Kfin Technologies Ltd.
Registrar Website: https://ipostatus.kfintech.com/
IPO Lead Manager(s)
Company Information
Address: Plot No. 101/A, Phase-III, Industrial Development Park, Cherlapally, Hindustan Cables Ltd, Uppal, Hyderabad, Telangana - 500051
Website: https://www.himalayanutravedics.com
Email: info@himalayanutravedics.com
Phone: +91-9063498493
IPO Documents
Frequently Asked Questions (FAQ)
Explore More Investment Opportunities
Discover IPOs, unlisted shares, and broker comparison tools curated for smart investors.